Mark R. Hanudel

Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference

Jodie L. Babitt, Michele F. Eisenga, Volker H. Haase et al. · Kidney International · 2021 · 204 citations · Full text

Effects of erythropoietin on fibroblast growth factor 23 in mice and humans

Mark R. Hanudel, Michele F. Eisenga, Maxime Rappaport et al. · Nephrology Dialysis Transplantation · 2018 · 93 citations · Full text

Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice

Mark R. Hanudel, Kristine J. Chua, Maxime Rappaport et al. · American Journal of Physiology-Renal Physiology · 2016 · 71 citations

Nutrition, Iron Metabolism, Pathology +19

High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort

Anjali Nayak, Aarti Luhar, Mark R. Hanudel et al. · Pediatric Nephrology · 2014 · 62 citations · Full text

Whole-body Vascular Imaging, Renal Function, Medical Imaging +11

Effects of acute kidney injury and chronic hypoxemia on fibroblast growth factor 23 levels in pediatric cardiac surgery patients

Mark R. Hanudel, Katherine Wesseling‐Perry, Barbara Gales et al. · Pediatric Nephrology · 2015 · 34 citations · Full text

Heart Failure, Fibrosis, Chronic Hypoxemia +10